YuanYe Tech Featured on CMG, Wins "2024 New Quality Productive Forces Case of the Year" Award | Linear Capital Portfolio Company

On January 20, 2025, China Media Group's "2024 New Quality Productive Forces Annual Gala" aired on CCTV-2 Finance Channel and the CCTV Finance app. Yrobot earned the "2024 New Quality Productive Forces Annual Case" award for its flagship product, the Muscle Suit.

For this selection, ten leading enterprises from across the country were chosen, spanning robotics, health and wellness, new energy, aerospace, materials, and other strategic priorities for national new quality productive forces. Yrobot's recognition underscores both its pioneering role in applying wearable robotics to healthcare and the high-level government attention being paid to industrial upgrading and innovation in this sector.

In recent years, as China's population ages and the number of chronic disease patients continues to grow, demand for rehabilitation medicine has expanded dramatically. Yet the rehabilitation industry suffers from notable shortcomings: a severe supply-demand mismatch, limitations of traditional care models, and surging demand for home-based recovery. The 19th National Congress report emphasized: "We must actively respond to population aging, improve policies and the social environment for elder care, filial piety, and respect for the elderly, promote integrated medical and elderly care, and accelerate the development of aging-related industries and programs." At the recent Central Economic Work Conference, leaders explicitly called for "taking technological innovation as the core driver to advance new quality productive forces and build a modern industrial system," with specific mention of "actively developing the silver economy."

As a practitioner of these guiding principles, Yrobot has continuously deepened its R&D efforts and answered the policy call with concrete action. The Muscle Suit, the world's first lightweight soft exoskeleton, is designed to provide intelligent assistance to people with limited mobility, including stroke patients, those with cerebral palsy, and Parkinson's disease patients.

The product has successfully broken through multiple constraints in structure, hardware, and software, achieving technical innovations in "lightweight comfort, intelligent customization, and precise assistance," while also pioneering a new industry model that shifts from passive training to active training. As the Muscle Suit becomes more widely adopted, it is expected to make home-based rehabilitation more feasible, reduce pressure on medical resources, and significantly improve the efficiency and coverage of rehabilitation services.

At the "2024 New Quality Productive Forces Annual Gala," the jury's assessment of the Muscle Suit was: "Every step forward carries the warmth of technology — and the dignity of life." This verdict affirms not only Yrobot's technological innovation but also its contribution to society. As an important driver of intelligent transformation in the rehabilitation industry, the Muscle Suit's success offers a "China solution" for global rehabilitation medicine development.

Going forward, Yrobot will continue to make technological innovation its core driving force, deepening research in wearable robotics, expanding application scenarios, and advancing intelligent development in rehabilitation and beyond. Ding Ye, Yrobot's founder and CEO, said: "Yrobot's growth isn't just about serving the rehabilitation industry — we want to use technology to change how more people live. We will further expand into the consumer market, launching more innovative products to make technology part of everyone's daily life."

About Linear Capital

Linear Capital is an early-stage investment firm focused on "frontier technology + industry," targeting frontier technologies — including data intelligence, digital new infrastructure, next-generation robotics, and technological transformation of traditional sectors (such as biomedicine, materials, and energy) — applied across vertical industries to dramatically improve industrial efficiency, solve pain points, enable industrial upgrading, and generate outsized commercial returns through substantial increases in industrial value. The firm currently manages ten funds with total AUM of approximately $2 billion.

We lead investments from angel through Series A, with check sizes ranging from $1 million to $10 million (or RMB equivalent).

To date, Linear Capital has made early-stage investments in more than 120 teams, including Horizon Robotics, Kujiale, Sensors Data, Tezign, Rokid, Guandata, and Agile Robots. The combined valuation of Linear's portfolio companies is approximately $20 billion. In the near term, Linear Capital is working to become the premier "Data Intelligence Technology Fund"; over the long term, it aims to build itself into the most influential "Frontier Technology Application Fund."